Status:
ACTIVE_NOT_RECRUITING
Virtual Diabetes Group Visits Across Health Systems
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Wake Forest University Health Sciences
ACCESS Community Health Network
Conditions:
T2DM (Type 2 Diabetes Mellitus)
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
Detailed Description
Managing diabetes can be complex and burdensome; patients must modify their diet, take medications, check their blood sugar, and visit their healthcare providers regularly. Diabetes group visits (GVs)...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient at a PARTICIPATING clinic (at least one visit in year prior to first GV)
- Type 2 diabetes
- ≥ 18 years old
- A1C\>8% within 6 months prior to first GV (we will first recruit patients with A1C\>9%, then if spaces still available A1C\>8.5%, then if spaces still available A1C\>8%)
- At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30)
- English or Spanish speaking
- PCP assented to recruiting patient
- Patient provides written consent
Exclusion
Key Trial Info
Start Date :
May 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT06094491
Start Date
May 3 2024
End Date
June 30 2026
Last Update
October 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Access Community Health Network
Chicago, Illinois, United States, 60661
2
Advocate Health Care
Orland Park, Illinois, United States, 60462